Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
147M
-
Number of holders
-
996
-
Total 13F shares, excl. options
-
124M
-
Shares change
-
-214K
-
Total reported value, excl. options
-
$29.6B
-
Value change
-
-$102M
-
Put/Call ratio
-
1.58
-
Number of buys
-
360
-
Number of sells
-
-541
-
Price
-
$239.92
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q4 2021
1,226 filings reported holding BIIB - BIOGEN INC. - COM as of Q4 2021.
BIOGEN INC. - COM (BIIB) has 996 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 124M shares
of 147M outstanding shares and own 84.23% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (15.8M shares), BlackRock Inc. (13.7M shares), VANGUARD GROUP INC (11.5M shares), STATE STREET CORP (7.01M shares), WELLINGTON MANAGEMENT GROUP LLP (6.18M shares), JPMORGAN CHASE & CO (4.54M shares), GEODE CAPITAL MANAGEMENT, LLC (2.75M shares), Clearbridge Investments, LLC (2.52M shares), NORTHERN TRUST CORP (1.69M shares), and DEUTSCHE BANK AG\ (1.57M shares).
This table shows the top 996 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.